Search bioRxiv⌕ Search

Biology subjects

Tiburzi, O.

Publications and source records attributed to Tiburzi, O..

3 recordsLinked to original sources

Machine Learning for Toxicity Prediction in Low-Sample Molecular Classes

Deep learning models such as Chemprop have advanced quantitative molecular property prediction, but their reliance on large training sets limits use in data-scarce domains. We propose a framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets. The resulting models retain the baseline's generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data. We demonstrate the approach on three toxicity classes defined by a common core structure, target, or mode of action: (i) organophosphates, (ii) androgen receptor antagonists, and (iii) estrogen receptor beta antagonists. Each fine-tuned model outperforms classical machine-learning methods and the EPA TEST tool. The probabilistic nature of the predictions enables prioritization of compounds for experimental validation and seamless integration with data streams of varying quality, supporting iterative decision-making in chemical safety and drug discovery.

biochemistry↗

Image-based Morphological Profiling Reveals Signatures of Radiation Exposure

Exposure to ionizing radiation has the potential to induce significant health risks including radiation sickness and death. Here, the utility of image-based morphological profiling (IBMP) assays was investigated as a method to visualize signatures of radiation over time. Human-derived fibroblasts were used as the model system, and were exposed to varying doses of radiation. Cell Painting protocols were then applied to generate images for profiling. Quantitative analysis of images taken from fibroblasts exposed to 1 Gray of ionizing radiation revealed considerable morphological changes by 24 hours post-exposure, with some morphological signs of exposure emerging as early as 4 hours post-exposure. This work demonstrates proof-of-concept for the use of cell painting and IBMP to visualize signatures of radiation, paving the way for its use as a tool for assessing repeated exposures, screening of potential treatments, and establishing relevant timepoints for downstream orthogonal assays.

cell biology↗

Design and Characterization of Lipid Nanocarriers for Oral Delivery of Immunotherapeutic Peptides

The use of therapeutic proteins and peptides is of great interest for the treatment of many diseases, and advances in nanotechnology offer a path toward their stable delivery via preferred routes of administration. In this study, we sought to design and formulate a nanostructured lipid carrier (NLC) containing a nominal antigen (insulin peptide) for oral delivery. We utilized the design of experiments (DOE) statistical method to determine the dependencies of formulation variables on physicochemical particle characteristics including particle size, polydispersity (PDI), melting point, and latent heat of melting. The particles were determined to be non-toxic in vitro, readily taken up by primary immune cells, and found to accumulate in regional lymph nodes following oral administration. We believe that this platform technology could be broadly useful for the treatment of autoimmune diseases by supporting the development of oral delivery-based antigen specific immunotherapies. Highlights3-5 bullets, 85 char or less O_LIA Design of Experiments method led the formulation of biocompatible nanoparticles C_LIO_LINLC accumulate into gut-draining lymphatic tissues following oral administration C_LIO_LINLC protect their antigen cargo and promote its presentation C_LIO_LINLC formulation is well-suited for oral delivery of immunomodulatory agents C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/478027v1_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@1d18054org.highwire.dtl.DTLVardef@14038ddorg.highwire.dtl.DTLVardef@1555abdorg.highwire.dtl.DTLVardef@b83a42_HPS_FORMAT_FIGEXP M_FIG The development of nanostructured lipid carriers containing a nominal antigen (insulin peptide) for oral delivery consists on (1) nanoparticle formulation using a statistical method, (2) in-vitro studies to assess cellular toxicity and uptake and T cell activation, and (3) in-vivo studies to assess bio-distribution. C_FIG

immunology↗